Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMS
DateTimeSourceHeadlineSymbolCompany
15/02/202211:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
26/01/202216:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/12/202113:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/12/202111:15Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202121:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202121:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202121:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202121:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202121:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202116:54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202116:47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202116:46Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202116:43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202114:28Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202114:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202114:17Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202114:12GlobeNewswire Inc.Supernus Pharmaceuticals Completes Acquisition of Adamas PharmaceuticalsNASDAQ:ADMSAdamas Pharmaceuticals Inc
23/11/202113:22Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
23/11/202113:00GlobeNewswire Inc.Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender OfferNASDAQ:ADMSAdamas Pharmaceuticals Inc
23/11/202111:05Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
18/11/202113:58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/11/202121:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
01/11/202120:55Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
25/10/202122:24Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
25/10/202116:26Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
25/10/202115:22Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ADMSAdamas Pharmaceuticals Inc
19/10/202121:27Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADMSAdamas Pharmaceuticals Inc
13/10/202122:14Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
12/10/202112:56Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
12/10/202112:05Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADMS

Your Recent History

Delayed Upgrade Clock